Explore

Trendline Trendline
Vertex Pharmaceuticals to Engage in Goldman Sachs Global Healthcare Conference with CEO Fireside Chat

Vertex Pharmaceuticals to Engage in Goldman Sachs Global Healthcare Conference with CEO Fireside Chat

Vertex Pharmaceuticals to Engage in Goldman Sachs Global Healthcare Conference with CEO Fireside Chat
Trendline Trendline
Arrowhead Pharmaceuticals to Participate in Major Healthcare Conferences in June 2026

Arrowhead Pharmaceuticals to Participate in Major Healthcare Conferences in June 2026

Arrowhead Pharmaceuticals to Participate in Major Healthcare Conferences in June 2026
Trendline Trendline
Alkermes to Engage in Goldman Sachs Healthcare Conference, Highlighting Neuroscience Innovations

Alkermes to Engage in Goldman Sachs Healthcare Conference, Highlighting Neuroscience Innovations

Alkermes to Engage in Goldman Sachs Healthcare Conference, Highlighting Neuroscience Innovations
Trendline Trendline
Contineum Therapeutics to Present at Goldman Sachs Global Healthcare Conference

Contineum Therapeutics to Present at Goldman Sachs Global Healthcare Conference

Contineum Therapeutics to Present at Goldman Sachs Global Healthcare Conference
Reuters Reuters
US FDA to review AI-based tool to predict drug-related liver damage

US FDA to review AI-based tool to predict drug-related liver damage

June 3 (Reuters) - The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted a letter of intent for an artificial intelligence-based drug development tool designed to help predict drug-induced liver injury.
Trendline Trendline
Cocrystal Pharma Appoints James Sapirstein as CEO to Advance Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Advance Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Advance Antiviral Development
Trendline Trendline
Contineum Therapeutics to Present at 2026 Goldman Sachs Global Healthcare Conference

Contineum Therapeutics to Present at 2026 Goldman Sachs Global Healthcare Conference

Contineum Therapeutics to Present at 2026 Goldman Sachs Global Healthcare Conference
Trendline Trendline
Vertex Pharmaceuticals Secures FDA Acceptance for Povetacicept in IgA Nephropathy

Vertex Pharmaceuticals Secures FDA Acceptance for Povetacicept in IgA Nephropathy

Vertex Pharmaceuticals Secures FDA Acceptance for Povetacicept in IgA Nephropathy
Trendline Trendline
Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development
Trendline Trendline
Circio and GenAssist Partner to Develop Gene Therapy for Muscle Disease

Circio and GenAssist Partner to Develop Gene Therapy for Muscle Disease

Circio and GenAssist Partner to Develop Gene Therapy for Muscle Disease
Trendline Trendline
Seaport Therapeutics to Engage in Key Investor Conferences Amidst Neuropsychiatric Drug Development

Seaport Therapeutics to Engage in Key Investor Conferences Amidst Neuropsychiatric Drug Development

Seaport Therapeutics to Engage in Key Investor Conferences Amidst Neuropsychiatric Drug Development
Trendline Trendline
Phosphorex Appoints John Rigg as Chairman to Enhance Drug Delivery Expertise

Phosphorex Appoints John Rigg as Chairman to Enhance Drug Delivery Expertise

Phosphorex Appoints John Rigg as Chairman to Enhance Drug Delivery Expertise